This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2009 by St. Claraspital AG.
Recruitment status was:  Recruiting
Information provided by:
St. Claraspital AG Identifier:
First received: February 2, 2009
Last updated: September 21, 2009
Last verified: September 2009
The purpose of this study is to determine whether markers on tumor tissue may be an indicator for good response to neoadjuvant chemoradiotherapy in patients with rectal cancer.

Rectal Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective

Further study details as provided by St. Claraspital AG:

Estimated Enrollment: 100
Study Start Date: April 2005

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
group is selected from a single institution ( community hospital)

Inclusion Criteria:

  • locally advanced rectal cancer uT3 or uT4
  • no distant metastasis
  • neoadjuvant radiochemotherapy required

Exclusion Criteria:

  • rejection of radiochemotherapy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00835055

Contact: Beatrice Kern, MD +41 61 685858585 ext 8484

St. Claraspital, Chirurgische Klinik Recruiting
Basel, Switzerland, 4016
Contact: Beatrice Kern, MD    +41 61 6858585 ext 8484   
Sponsors and Collaborators
St. Claraspital AG
  More Information

Responsible Party: Dr. Urs Wagner, Viollier AG Identifier: NCT00835055     History of Changes
Other Study ID Numbers: 43/05
Study First Received: February 2, 2009
Last Updated: September 21, 2009

Keywords provided by St. Claraspital AG:
rectal cancer with neoadjuvant treatment
standardized clinical tests
tumor markers on tumor tissue

Additional relevant MeSH terms:
Rectal Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Rectal Diseases processed this record on September 21, 2017